LINC00174 has been shown to as an oncogenic lncRNA in a variety of cancer [10, , , -14], for example, LINC00174 promotes glycolysis and tumor progression by regulating miR-152-3p/SLC2A1 axis in glioma [10]; Silencing of LINC00174 decreases chemoresistance to temozolomide in human glioma cells by regulating miR-138-5p/SOX9 axis [11]. The gene discussed is SLC2A1; the disease is central nervous system cancer.